Platelet Function in Patients Undergoing PCI NCT01267708

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Details — Status: Recruiting

The purpose of this study is to examine PLT function in PCI patients.

Recruitment information / eligibility
Status	Recruiting
Enrollment	1500
Est. completion date
Est. primary completion date
Accepts healthy volunteers	No
Gender	Both
Age group	18 Years and older
Eligibility	Inclusion Criteria: - All consented patients undergoing PCI Exclusion Criteria: - Unable to consent

Observational Model: Cohort, Time Perspective: Prospective

Locations
Country	Name	City	State
Israel	Rambam Medical Center	Haifa

Sponsors *(1)*
Lead Sponsor	Collaborator
Rambam Health Care Campus

Israel,